Jeffrey R. Spencer

Development of Serine Protease Inhibitors Displaying a Multicentered Short (<2.3 Å) Hydrogen Bond Binding Mode:  Inhibitors of Urokinase-Type Plasminogen Activator and Factor Xa

Erik Verner, B.A. Katz, Jeffrey R. Spencer et al. · Journal of Medicinal Chemistry · 2001 · 124 citations · Full text

Drug Target, Bioorganic Chemistry, Serine Protease Inhibitors +19

A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site11Edited by D. Rees

B.A. Katz, Kyle Elrod, Christine Luong et al. · Journal of Molecular Biology · 2001 · 76 citations · Full text

Protein Assembly, Biochemistry, Protein Folding +9

Comparative study of methods to couple hindered peptides

Jeffrey R. Spencer, Valery V. Antonenko, Nancy G. J. Delaet et al. · International journal of peptide & protein research · 1992 · 75 citations

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

B.A. Katz, Paul A. Sprengeler, Christine Luong et al. · Chemistry & Biology · 2001 · 67 citations · Full text

Protease Inhibitors, Protein Function, Drug Target +10

Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G

Jonathan W. Lane, Alberto Estevez, Kyle Mortara et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 58 citations · Full text

Medicinal Chemistry, Antitumor Activity, Medicine +5